Research and Markets: United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery - Volume 2: Patient Perspectives

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rgbgwp/united_states) has announced the addition of Frost & Sullivan's new report "United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery - Volume 2: Patient Perspectives" to their offering.

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and parameters for delivery of drugs in outpatient settings, particularly the home. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments. This research examines the awareness and utilization of oncology drug delivery methods, the perceptions, attitudes and willingness to use various methods, and the preference for and satisfaction with each method.

Objectives

- Understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients in key treatment settings such as home, office, or infusion center.

- Identify physician prescribing trends relative to drug delivery considerations.

- Understanding the role of reimbursement in physician's choice of drug delivery.

- Identify physicians' perception of different drug delivery approaches, as well as key drivers for adoption/non-adoption, compliance, and choice of delivery devices.

- Identify drug delivery trends within the oncology area.

- Determine product attributes relative to delivery that are considered to be important by physicians and patients.

- Identify prospective patient preferences and willingness to try new technologies as well as determine key drivers of adoption/non-adoption.

The eleven drug delivery categories evaluated in this research are:

- Intravenous injection

- Subcutaneous (SC) injection

- Intramuscular (IM) injection

- Intravenous infusion

- Implantable infusion pump

- External infusion pump

- Transdermal patch

- Topical gel or cream

- Implant

- Oral

- Rectal

Key Topics Covered:

1. Research Objectives and Methods

2. Executive Summary and Implications

3. Profile of Respondents

4. Awareness and Utilization of Oncology Drug Delivery Methods

5. Perceptions, Attitudes and Willingness to Use Drug Delivery Methods

6. Preference for and Satisfaction with Drug Delivery Methods

7. Preferred Setting for Treatment

8. Profile of Patients' Compliance

9. Criteria of Drug Delivery Selection

10. The Frost & Sullivan Story

For more information visit http://www.researchandmarkets.com/research/rgbgwp/united_states

Source: Frost & Sullivan

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery, Oncology

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery, Oncology